Cargando…
A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application()()
The new zoonotic coronavirus (SARS-CoV-2) responsible for coronavirus disease (COVID-19) is a new strain of coronavirus not previously seen in humans and which appears to come from bat species. It originated in Wuhan, Hubei Province, China, and spread rapidly throughout the world, causing over 5,569...
Autores principales: | Contini, Carlo, Enrica Gallenga, Carla, Neri, Giampiero, Maritati, Martina, Conti, Pio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246020/ https://www.ncbi.nlm.nih.gov/pubmed/32562915 http://dx.doi.org/10.1016/j.mehy.2020.109876 |
Ejemplares similares
-
Macrophage Activation in Follicular Conjunctivitis during the COVID-19 Pandemic
por: Gallenga, Carla Enrica, et al.
Publicado: (2023) -
Sodium chromo-glycate and palmitoylethanolamide: A possible strategy to treat mast cell-induced lung inflammation in COVID-19
por: Gigante, Antonio, et al.
Publicado: (2020) -
Advanced Molecular and Immunological Diagnostic Methods to Detect SARS-CoV-2 Infection
por: Rotondo, John Charles, et al.
Publicado: (2022) -
Evaluation of Anti-SARS-CoV-2 IgA Response in Tears of Vaccinated COVID-19 Subjects
por: Soffritti, Irene, et al.
Publicado: (2023) -
A comparison between different anti-retroviral therapy regimes on soluble inflammation markers: a pilot study
por: Maritati, Martina, et al.
Publicado: (2020)